EMERGING BIOTECH

Drive Launch Success

Go to market more effectively with a well-orchestrated launch
Assess Launch Readiness
Increasing competition
+48%
in number of approved drugs since 2018
Unmet expectations
36%
of drugs failed to meet market expectations in the first year
High stakes
70%
of products that miss launch expectations continue to underperform

Pre-commercial guide to launch excellence

Identify the right mix of go-to-market plans and operational capabilities in this pre-commercial roadmap for biopharmas.

Download eBook
“With Veeva as our trusted partner, we accelerated launch readiness and equipped new sales, medical, and marketing teams with the digital tools they need.”

Christopher Mutz, Chief Commercial Officer & Head of Rare Disease, ANI Pharmaceuticals

Product launch tips and best practices

G1 Therapeutics: The importance of a data-driven launch Watch the video
Treatment adoption 40% faster with targeted scientific outreach Read report
Insmed: Blueprint for commercial excellence Watch the video

Launch solutions for emerging biotech

Learn why hundreds of pre-commerial companies rely on Veeva to plan and execute their launch.

Veeva Medical Solutions

Unify scientific exchange, content, inquiry management, and real-time intelligence.

Veeva Vault CRM Suite

Integrate key commercial applications and processes for more effective field engagement.

Veeva Vault PromoMats

Manage the approval, storage, and distribution of promotional content.

Veeva OpenData

Support launch with global customer reference data.

Veeva Link

Identify and engage the right people with real-time customer intelligence.

Veeva Compass

Find more patients and HCPs for launch with patient and prescriber data.

Ready to launch with confidence?

Contact Us

Contact Us